UNICK FIX-A-FORM AND PRINTERS | NORRIS MEDICINES | UNICK FIX-A-FORM AND PRINTERS/ NORRIS MEDICINES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | -6.5 | - | View Chart |
P/BV | x | 1.1 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS NORRIS MEDICINES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
NORRIS MEDICINES Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ NORRIS MEDICINES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 33 | 177.6% | |
Low | Rs | 32 | 8 | 389.4% | |
Sales per share (Unadj.) | Rs | 120.5 | 8.4 | 1,442.1% | |
Earnings per share (Unadj.) | Rs | 4.1 | -1.7 | -233.4% | |
Cash flow per share (Unadj.) | Rs | 11.2 | -1.1 | -1,001.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | -12.4 | -433.2% | |
Shares outstanding (eoy) | m | 5.49 | 10.00 | 54.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 2.5 | 15.2% | |
Avg P/E ratio | x | 11.1 | -11.8 | -93.8% | |
P/CF ratio (eoy) | x | 4.0 | -18.5 | -21.8% | |
Price / Book Value ratio | x | 0.8 | -1.7 | -50.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 207 | 120.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 23 | 390.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 84 | 791.7% | |
Other income | Rs m | 5 | 0 | 3,650.0% | |
Total revenues | Rs m | 667 | 84 | 796.4% | |
Gross profit | Rs m | 88 | 9 | 951.8% | |
Depreciation | Rs m | 39 | 6 | 621.7% | |
Interest | Rs m | 24 | 15 | 158.8% | |
Profit before tax | Rs m | 30 | -12 | -250.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 6 | 134.4% | |
Profit after tax | Rs m | 22 | -17 | -128.1% | |
Gross profit margin | % | 13.3 | 11.0 | 120.2% | |
Effective tax rate | % | 25.0 | -46.6 | -53.6% | |
Net profit margin | % | 3.4 | -20.9 | -16.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 49 | 611.7% | |
Current liabilities | Rs m | 287 | 77 | 372.4% | |
Net working cap to sales | % | 2.1 | -33.3 | -6.4% | |
Current ratio | x | 1.0 | 0.6 | 164.3% | |
Inventory Days | Days | 4 | 54 | 7.1% | |
Debtors Days | Days | 72,349,839 | 48,053,407 | 150.6% | |
Net fixed assets | Rs m | 402 | 77 | 520.7% | |
Share capital | Rs m | 55 | 99 | 55.3% | |
"Free" reserves | Rs m | 241 | -224 | -107.8% | |
Net worth | Rs m | 296 | -124 | -237.8% | |
Long term debt | Rs m | 89 | 184 | 48.2% | |
Total assets | Rs m | 705 | 126 | 558.4% | |
Interest coverage | x | 2.3 | 0.2 | 1,101.5% | |
Debt to equity ratio | x | 0.3 | -1.5 | -20.2% | |
Sales to assets ratio | x | 0.9 | 0.7 | 141.8% | |
Return on assets | % | 6.6 | -2.0 | -332.2% | |
Return on equity | % | 7.6 | 14.1 | 53.9% | |
Return on capital | % | 14.0 | 5.1 | 272.1% | |
Exports to sales | % | 0 | 2.4 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 2 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 2 | 0.0% | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 2 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 12 | 364.0% | |
From Investments | Rs m | -27 | NA | 12,281.8% | |
From Financial Activity | Rs m | -16 | -12 | 138.6% | |
Net Cashflow | Rs m | 0 | 0 | 1,750.0% |
Indian Promoters | % | 71.6 | 34.0 | 210.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.1 | 642.9% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 66.0 | 43.1% | |
Shareholders | 1,622 | 25,517 | 6.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | NORRIS MEDI. | S&P BSE TECK |
---|---|---|---|
1-Day | -0.24% | -1.97% | 0.09% |
1-Month | 20.94% | -10.52% | -1.27% |
1-Year | 60.10% | 7.35% | 26.36% |
3-Year CAGR | 30.20% | 3.66% | 10.29% |
5-Year CAGR | 21.75% | 14.54% | 14.89% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the NORRIS MEDI. share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of NORRIS MEDI. the stake stands at 34.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of NORRIS MEDI..
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
NORRIS MEDI. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of NORRIS MEDI..
For a sector overview, read our media sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.